Srikanth Yandrapalli, Maya Pandit, Aaqib Malik, Kanika Gupta, Christopher Nabors, Diwakar Jain, William Frishman, Wilbert S Aronow
{"title":"慢性阻塞性肺疾病对急性心肌梗死后心力衰竭住院的影响","authors":"Srikanth Yandrapalli, Maya Pandit, Aaqib Malik, Kanika Gupta, Christopher Nabors, Diwakar Jain, William Frishman, Wilbert S Aronow","doi":"10.5114/amsad/162014","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The presence of chronic obstructive pulmonary disease (COPD) can impact the management of acute myocardial infarction (AMI) and is associated with higher mortality. Few studies addressed COPD impact on heart failure hospitalisations (HFHs) in AMI survivors.</p><p><strong>Material and methods: </strong>Adult survivors of an AMI between January and June 2014 were identified from the US Nationwide Readmissions Database. The impact of COPD on HFH within 6 months, fatal HFH and the composite of in-hospital HF or 6-month HFH was studied.</p><p><strong>Results: </strong>Of 237,549 AMI survivors, patients with COPD (17.5%) were older, more likely female, had a higher prevalence of cardiac comorbidities and a lower coronary revascularization rate. In-hospital HF was more frequent in patients with COPD (47.0% vs. 25.4%; <i>p</i> < 0.001). HFH within 6 months occured in 12,934 (5.4%) patients, at a 114% higher rate in patients with COPD (9.4% vs. 4.6%, OR = 2.14, 95% CI : 2.01-2.29; <i>p</i> < 0.001), which was attenuated to a 39% higher adjusted risk (OR = 1.39, 95% CI: 1.30-1.49). Findings were consistent across subgroups of age, AMI type, and major HF risk factors. Mortality during a HFH (5.7% vs. 4.2%, <i>p</i> < 0.001) and the rate of the composite HF outcome (49.0% vs. 26.9%, <i>p</i> < 0.001) were significantly higher in patients with COPD.</p><p><strong>Conclusions: </strong>COPD was present in 1 of 6 AMI survivors and was associated with worse HF related outcomes. The increased HFH rate in COPD patients was consistent across several clinically relevant subgroups and these findings highlight the need for optimal in-hospital and post-discharge management of these higher-risk patients.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/d6/AMS-AD-8-162014.PMC10161788.pdf","citationCount":"0","resultStr":"{\"title\":\"Impact of chronic obstructive pulmonary disease on heart failure hospitalizations after an acute myocardial infarction.\",\"authors\":\"Srikanth Yandrapalli, Maya Pandit, Aaqib Malik, Kanika Gupta, Christopher Nabors, Diwakar Jain, William Frishman, Wilbert S Aronow\",\"doi\":\"10.5114/amsad/162014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The presence of chronic obstructive pulmonary disease (COPD) can impact the management of acute myocardial infarction (AMI) and is associated with higher mortality. Few studies addressed COPD impact on heart failure hospitalisations (HFHs) in AMI survivors.</p><p><strong>Material and methods: </strong>Adult survivors of an AMI between January and June 2014 were identified from the US Nationwide Readmissions Database. The impact of COPD on HFH within 6 months, fatal HFH and the composite of in-hospital HF or 6-month HFH was studied.</p><p><strong>Results: </strong>Of 237,549 AMI survivors, patients with COPD (17.5%) were older, more likely female, had a higher prevalence of cardiac comorbidities and a lower coronary revascularization rate. In-hospital HF was more frequent in patients with COPD (47.0% vs. 25.4%; <i>p</i> < 0.001). HFH within 6 months occured in 12,934 (5.4%) patients, at a 114% higher rate in patients with COPD (9.4% vs. 4.6%, OR = 2.14, 95% CI : 2.01-2.29; <i>p</i> < 0.001), which was attenuated to a 39% higher adjusted risk (OR = 1.39, 95% CI: 1.30-1.49). Findings were consistent across subgroups of age, AMI type, and major HF risk factors. Mortality during a HFH (5.7% vs. 4.2%, <i>p</i> < 0.001) and the rate of the composite HF outcome (49.0% vs. 26.9%, <i>p</i> < 0.001) were significantly higher in patients with COPD.</p><p><strong>Conclusions: </strong>COPD was present in 1 of 6 AMI survivors and was associated with worse HF related outcomes. The increased HFH rate in COPD patients was consistent across several clinically relevant subgroups and these findings highlight the need for optimal in-hospital and post-discharge management of these higher-risk patients.</p>\",\"PeriodicalId\":8317,\"journal\":{\"name\":\"Archives of Medical Sciences. Atherosclerotic Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/d6/AMS-AD-8-162014.PMC10161788.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Medical Sciences. Atherosclerotic Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/amsad/162014\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Medical Sciences. Atherosclerotic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/amsad/162014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
慢性阻塞性肺疾病(COPD)的存在会影响急性心肌梗死(AMI)的管理,并与较高的死亡率相关。很少有研究涉及慢性阻塞性肺病对AMI幸存者心力衰竭住院(HFHs)的影响。材料和方法:2014年1月至6月期间AMI的成年幸存者从美国全国再入院数据库中确定。研究COPD对6个月内HFH、致死性HFH、院内HF或6个月HFH复合的影响。结果:在237,549例AMI幸存者中,COPD患者(17.5%)年龄较大,更可能为女性,心脏合并症患病率较高,冠状动脉重建率较低。院内HF在COPD患者中更为常见(47.0% vs 25.4%;P < 0.001)。6个月内HFH发生在12,934例(5.4%)患者中,COPD患者的发生率高114%(9.4%比4.6%,OR = 2.14, 95% CI: 2.01-2.29;p < 0.001),调整后的风险降低到39% (OR = 1.39, 95% CI: 1.30-1.49)。研究结果在年龄、AMI类型和主要HF危险因素的亚组中是一致的。慢性阻塞性肺病患者HFH期间的死亡率(5.7% vs. 4.2%, p < 0.001)和复合HF结局率(49.0% vs. 26.9%, p < 0.001)显著高于慢性阻塞性肺病患者。结论:6名AMI幸存者中有1名存在COPD,并且与心衰相关的预后较差相关。慢性阻塞性肺病患者HFH率的增加在几个临床相关亚组中是一致的,这些发现强调了对这些高风险患者进行最佳住院和出院后管理的必要性。
Impact of chronic obstructive pulmonary disease on heart failure hospitalizations after an acute myocardial infarction.
Introduction: The presence of chronic obstructive pulmonary disease (COPD) can impact the management of acute myocardial infarction (AMI) and is associated with higher mortality. Few studies addressed COPD impact on heart failure hospitalisations (HFHs) in AMI survivors.
Material and methods: Adult survivors of an AMI between January and June 2014 were identified from the US Nationwide Readmissions Database. The impact of COPD on HFH within 6 months, fatal HFH and the composite of in-hospital HF or 6-month HFH was studied.
Results: Of 237,549 AMI survivors, patients with COPD (17.5%) were older, more likely female, had a higher prevalence of cardiac comorbidities and a lower coronary revascularization rate. In-hospital HF was more frequent in patients with COPD (47.0% vs. 25.4%; p < 0.001). HFH within 6 months occured in 12,934 (5.4%) patients, at a 114% higher rate in patients with COPD (9.4% vs. 4.6%, OR = 2.14, 95% CI : 2.01-2.29; p < 0.001), which was attenuated to a 39% higher adjusted risk (OR = 1.39, 95% CI: 1.30-1.49). Findings were consistent across subgroups of age, AMI type, and major HF risk factors. Mortality during a HFH (5.7% vs. 4.2%, p < 0.001) and the rate of the composite HF outcome (49.0% vs. 26.9%, p < 0.001) were significantly higher in patients with COPD.
Conclusions: COPD was present in 1 of 6 AMI survivors and was associated with worse HF related outcomes. The increased HFH rate in COPD patients was consistent across several clinically relevant subgroups and these findings highlight the need for optimal in-hospital and post-discharge management of these higher-risk patients.